1-20 of 23
Carl H. June
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74

Iris K. Lee, Estela Noguera-Ortega, Zebin Xiao, Leslie Todd, John Scholler, Decheng Song, Maria Liousia, Katheryn Lohith, Kexiang Xu, Kimberly J. Edwards, Michael D. Farwell, Carl H. June, Steven M. Albelda, Ellen Puré, Mark A. Sellmyer
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5330–5342.
https://doi.org/10.1158/1078-0432.CCR-22-1379
Published: 15 December 2022
View article titled, Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [<sup>18</sup>F]AlF-FAPI-74
Open the PDF for Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [<sup>18</sup>F]AlF-FAPI-74 in another window
Includes: Multimedia, Supplementary data
Journal Articles

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Caroline Diorio, Rawan Shraim, Regina Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M. DiNofia, Saar Gill, Vanessa Gonzalez, Michele P. Lambert, Allison Barz Leahy, Bruce L. Levine, Robert B. Lindell, Shannon L. Maude, J. Joseph Melenhorst, Haley Newman, Jessica Perazzelli, Alix E. Seif, Simon F. Lacey, Carl H. June, David M. Barrett, Stephan A. Grupp, David T. Teachey
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3804–3813.
https://doi.org/10.1158/1078-0432.CCR-22-0822
Published: 01 September 2022
View article titled, Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
Open the PDF for Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19 in another window
Includes: Supplementary data
Journal Articles

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer

Tanya B. Dorff, Vivek Narayan, Stephen J. Forman, Peter D. Zang, Joseph A. Fraietta, Carl H. June, Naomi B. Haas, Saul J. Priceman
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 576–584.
https://doi.org/10.1158/1078-0432.CCR-21-1483
Published: 15 February 2022
View article titled, Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
Open the PDF for Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer in another window
Journal Articles

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

Shwetha H. Manjunath, Adam D. Cohen, Simon F. Lacey, Megan M. Davis, Alfred L. Garfall, J. Joseph Melenhorst, Russell Maxwell, W. Tristram Arscott, Amit Maity, Joshua A. Jones, John P. Plastaras, Edward A. Stadtmauer, Bruce L. Levine, Carl H. June, Michael C. Milone, Ima Paydar
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6580–6590.
https://doi.org/10.1158/1078-0432.CCR-21-0308
Published: 01 December 2021
View article titled, The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
Open the PDF for The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies

Bryan D. Choi, Marcela V. Maus, Carl H. June, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2042–2048.
https://doi.org/10.1158/1078-0432.CCR-18-1625
Published: 01 April 2019
View article titled, Immunotherapy for Glioblastoma: Adoptive T-cell Strategies
Open the PDF for Immunotherapy for Glioblastoma: Adoptive T-cell Strategies in another window
Journal Articles

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

Karen Thudium Mueller, Edward Waldron, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Jason Hamilton, Rakesh Awasthi, Andrew M. Stein, Denise Sickert, Abhijit Chakraborty, Bruce L. Levine, Carl H. June, Lori Tomassian, Sweta S. Shah, Mimi Leung, Tetiana Taran, Patricia A. Wood, Shannon L. Maude
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6175–6184.
https://doi.org/10.1158/1078-0432.CCR-18-0758
Published: 13 December 2018
View article titled, Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
Open the PDF for Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia in another window
Includes: Supplementary data
Journal Articles

CAR T-Cell Therapies in Glioblastoma: A First Look

Denis Migliorini, Pierre-Yves Dietrich, Roger Stupp, Gerald P. Linette, Avery D. Posey, Jr, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (3): 535–540.
https://doi.org/10.1158/1078-0432.CCR-17-2871
Published: 31 January 2018
View article titled, CAR T-Cell Therapies in Glioblastoma: A First Look
Open the PDF for CAR T-Cell Therapies in Glioblastoma: A First Look in another window
Journal Articles

Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition

Jiangtao Ren, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H. June, Yangbing Zhao
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (9): 2255–2266.
https://doi.org/10.1158/1078-0432.CCR-16-1300
Published: 30 April 2017
View article titled, Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Open the PDF for Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition in another window
Includes: Supplementary data
Journal Articles

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma

Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nunez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael Milone, Simon F. Lacey, Anthony Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill, Mariusz A. Wasik
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2684–2696.
https://doi.org/10.1158/1078-0432.CCR-15-1527
Published: 31 May 2016
View article titled, The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Open the PDF for The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

Marcela V. Maus, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (8): 1875–1884.
https://doi.org/10.1158/1078-0432.CCR-15-1433
Published: 14 April 2016
View article titled, Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Open the PDF for Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy in another window
Journal Articles

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

Miriam E. Mossoba, David C. Halverson, Roger Kurlander, Bazetta Blacklock Schuver, Ashley Carpenter, Brenna Hansen, Seth M. Steinberg, Syed Abbas Ali, Nishant Tageja, Frances T. Hakim, Juan Gea-Banacloche, Claude Sportes, Nancy M. Hardy, Dennis D. Hickstein, Steven Z. Pavletic, Hanh Khuu, Marianna Sabatini, David Stroncek, Bruce L. Levine, Carl H. June, Jacopo Mariotti, Olivier Rixe, Antonio Tito Fojo, Michael R. Bishop, Ronald E. Gress, Daniel H. Fowler
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4312–4320.
https://doi.org/10.1158/1078-0432.CCR-15-0340
Published: 30 September 2015
View article titled, High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Open the PDF for High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses in another window
Journal Articles

Abstract IA10: CARs for leukemia and beyond?

Carl H. June, David Porter, Stephan Grupp, Bruce L. Levine
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17_Supplement): IA10.
https://doi.org/10.1158/1557-3265.HEMMAL14-IA10
Published: 19 August 2015
View article titled, Abstract IA10: CARs for leukemia and beyond?
Journal Articles

The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy

Emese Zsiros, Priyanka Duttagupta, Denarda Dangaj, Hongzhe Li, Renee Frank, Thomas Garrabrant, Ian S. Hagemann, Bruce L. Levine, Carl H. June, Lin Zhang, Ena Wang, Francesco M. Marincola, Davide Bedognetti, Daniel J. Powell, Jr, Janos Tanyi, Michael D. Feldman, Lana E. Kandalaft, George Coukos
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2840–2850.
https://doi.org/10.1158/1078-0432.CCR-14-2777
Published: 14 June 2015
View article titled, The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy
Open the PDF for The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy in another window
Includes: Supplementary data
Journal Articles

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, Caleph B. Wilson, Raghuveer Ranganathan, Jing Sun, Veena Kapoor, John Scholler, Ellen Puré, Michael C. Milone, Carl H. June, James L. Riley, E. John Wherry, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4262–4273.
https://doi.org/10.1158/1078-0432.CCR-13-2627
Published: 13 August 2014
View article titled, Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
Open the PDF for Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors in another window
Includes: Supplementary data
Journal Articles

CARTs on the Road for Myeloma

Marcela V. Maus, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (15): 3899–3901.
https://doi.org/10.1158/1078-0432.CCR-14-0721
Published: 31 July 2014
View article titled, CARTs on the Road for Myeloma
Open the PDF for CARTs on the Road for Myeloma in another window
Journal Articles

Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Dan T. Vogl, Yin Yan Xu, Michael Kalos, Ling Cai, Hong-Bin Fang, Brendan M. Weiss, Ashraf Badros, Saul Yanovich, Gorgun Akpek, Patricia Tsao, Alan Cross, Dean Mann, Sunita Philip, Naseem Kerr, Andrea Brennan, Zhaohui Zheng, Kathleen Ruehle, Todd Milliron, Scott E. Strome, Andres M. Salazar, Bruce L. Levine, Carl H. June
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (5): 1355–1365.
https://doi.org/10.1158/1078-0432.CCR-13-2817
Published: 02 March 2014
View article titled, Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Open the PDF for Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells in another window
Includes: Supplementary data
Journal Articles

Zoom Zoom: Racing CARs for Multiple Myeloma

Marcela V. Maus, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 1917–1919.
https://doi.org/10.1158/1078-0432.CCR-13-0168
Published: 15 April 2013
View article titled, Zoom Zoom: Racing CARs for Multiple Myeloma
Open the PDF for Zoom Zoom: Racing CARs for Multiple Myeloma in another window
Journal Articles

Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma

Stephan A. Grupp, Eline Luning Prak, Jean Boyer, Kenyetta R. McDonald, Suzanne Shusterman, Edward Thompson, Colleen Callahan, Abbas F. Jawad, Bruce L. Levine, Carl H. June, Kathleen E. Sullivan
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (24): 6732–6741.
https://doi.org/10.1158/1078-0432.CCR-12-1432
Published: 16 December 2012
View article titled, Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma
Open the PDF for Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

Nancy M. Hardy, Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiao-Yi Yan, Frances T. Hakim, Rebecca R. Babb, Daniele Avila, Juan Gea-Banacloche, Claude Sportès, Bruce L. Levine, Carl H. June, Hahn M. Khuu, Ashley E. Carpenter, Michael C. Krumlauf, Andrew J. Dwyer, Ronald E. Gress, Daniel H. Fowler, Michael R. Bishop
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6878–6887.
https://doi.org/10.1158/1078-0432.CCR-11-1579
Published: 31 October 2011
View article titled, Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer
Open the PDF for Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

Edmund K. Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S. Wang, Veena Kapoor, Jarrod Predina, Daniel J. Powell, Jr., James L. Riley, Carl H. June, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4719–4730.
https://doi.org/10.1158/1078-0432.CCR-11-0351
Published: 17 July 2011
View article titled, Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Open the PDF for Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor in another window
Includes: Supplementary data